Baldwin Wealth Partners’s General Moly, Inc. GMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,500
Closed 577
2020
Q3
$0 Hold
2,500
﹤0.01% 557
2020
Q2
$1K Hold
2,500
﹤0.01% 527
2020
Q1
$0 Hold
2,500
﹤0.01% 580
2019
Q4
$1K Hold
2,500
﹤0.01% 536
2019
Q3
$1K Hold
2,500
﹤0.01% 518
2019
Q2
$1K Hold
2,500
﹤0.01% 506
2019
Q1
$1K Hold
2,500
﹤0.01% 504
2018
Q4
$1K Hold
2,500
﹤0.01% 498
2018
Q3
$1K Hold
2,500
﹤0.01% 511
2018
Q2
$1K Hold
2,500
﹤0.01% 504
2018
Q1
$1K Hold
2,500
﹤0.01% 482
2017
Q4
$1K Sell
2,500
-750
-23% -$239 ﹤0.01% 465
2017
Q3
$1K Hold
3,250
﹤0.01% 473
2017
Q2
$1K Hold
3,250
﹤0.01% 466
2017
Q1
$2K Sell
3,250
-2,500
-43% -$1.2K ﹤0.01% 477
2016
Q4
$1K Hold
5,750
﹤0.01% 506
2016
Q3
$2K Hold
5,750
﹤0.01% 514
2016
Q2
$2K Hold
5,750
﹤0.01% 441
2016
Q1
$2K Buy
+5,750
New +$1.37K ﹤0.01% 470

Other funds holding GMO

Baldwin Wealth Partners's GMO Position: Q4 2020 in Review

Baldwin Wealth Partners sold out of General Moly, Inc. (GMO) in Q4 2020, closing a stake of 2,500 shares.

Baldwin Wealth Partners first reported a position in GMO in Q1 2016 and held it in 19 quarters. The position peaked at $2K in Q1 2017. 7 funds tracked by Wall St. Rank hold GMO as of Q4 2020.

  • Baldwin Wealth Partners reported no remaining General Moly, Inc. position as of Q4 2020 after selling out during the quarter.
  • Baldwin Wealth Partners sold 2,500 General Moly, Inc. shares in Q4 2020.
  • Baldwin Wealth Partners first reported a position in General Moly, Inc. in Q1 2016 and held it in 19 quarters.
  • Baldwin Wealth Partners's General Moly, Inc. position peaked at $2K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2020.

Based on Baldwin Wealth Partners's 13F filing for Q4 2020, filed 12 Jan 2021.